BRD4-BD1/2-IN-3 Preis auf Anfrage

Artikelnummer: MCE-HY-178041
Artikelname: BRD4-BD1/2-IN-3 Preis auf Anfrage
Artikelnummer: MCE-HY-178041
Hersteller Artikelnummer: HY-178041
Alternativnummer: MCE-HY-178041-5MG,MCE-HY-178041-50MG,MCE-HY-178041-100MG,MCE-HY-178041-10MG,MCE-HY-178041-25MG
Hersteller: MedchemExpress
Kategorie: Biochemikalien
BRD4-BD1/2-IN-3 (Compound B6) is a selective BRD4 BD2 inhibitor with an IC50 of 0.41 nM for BRD4 BD2 over BRD4 BD1. BRD4-BD1/2-IN-3 significantly inhibits the LPS (HY-D1056)-induced expression of IL-6. BRD4-BD1/2-IN-3 shows anti-inflammatory activities by modulating the TNF and NF-kappaB signaling pathway. BRD4-BD1/2-IN-3 can be used for inflammatory diseases research[1].
Molekulargewicht: 362.38
Reinheit: 99.52
Formel: C20H18N4O3
Target-Kategorie: c-Fms,Epigenetic Reader Domain,Interleukin Related,NF-kappaB,TNF Receptor
Anwendungsbeschreibung: MCE Product type: Reference compound